About NewLeaf Symbiotics
NewLeaf Symbiotics is a company based in St. Louis (United States) founded in 2011 by Stephen Kahn.. NewLeaf Symbiotics has raised $181 million across 11 funding rounds from investors including SABIC, Bayer and Monsanto. NewLeaf Symbiotics has completed 1 acquisition, including Intuitive Genomics. NewLeaf Symbiotics offers products and services including TS201 Corn Bioinsecticide, Terrasym 450 Corn Biostimulant, Terrasym 401 Soybean Biostimulant, TS601 Biofungicide, and Terrasym 402 Peanut Biostimulant. NewLeaf Symbiotics operates in a competitive market with competitors including Pivot Bio, Ginkgo Bioworks, Kula Bio, BioConsortia and Pluton Biosciences, among others.
- Headquarter St. Louis, United States
- Founders Stephen Kahn
-
Sectors
Chemicals & MaterialsAgriculture
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Newleaf Symbiotics
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$181 M (USD)
in 11 rounds
-
Latest Funding Round
$47.01 M (USD), Series D
Dec 12, 2023
-
Investors
SABIC
& 12 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NewLeaf Symbiotics
NewLeaf Symbiotics offers a comprehensive portfolio of products and services, including TS201 Corn Bioinsecticide, Terrasym 450 Corn Biostimulant, Terrasym 401 Soybean Biostimulant, TS601 Biofungicide, and Terrasym 402 Peanut Biostimulant. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Protects corn from pests like CRW to increase yields.
Enhances corn growth and yields through biological application.
Improves soybean productivity in various field conditions.
Controls fungal issues in soybean crops effectively.
Boosts peanut yields by enhancing soil and plant health.
Supports tomato transplant growth for better crop performance.
Unlock access to complete
Funding Insights of NewLeaf Symbiotics
NewLeaf Symbiotics has successfully raised a total of $181M across 11 strategic funding rounds. The most recent funding activity was a Series D round of $47.01 million completed in December 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Series D — $47.0M
-
First Round
First Round
(03 Nov 2011)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Series D - NewLeaf Symbiotics | Valuation | Gullspang Re:food | |
| Dec, 2022 | Amount | Series D - NewLeaf Symbiotics | Valuation |
investors |
|
| Dec, 2020 | Amount | Series D - NewLeaf Symbiotics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in NewLeaf Symbiotics
NewLeaf Symbiotics has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include SABIC, Bayer and Monsanto. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Limited information is provided about Otter Capital's activities.
|
Founded Year | Domain | Location | |
|
Stage agnostic venture capital firm
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life sciences sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by NewLeaf Symbiotics
NewLeaf Symbiotics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Intuitive Genomics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Custom bioinformatics solutions are provided for genome-scale data analysis.
|
2010 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - NewLeaf Symbiotics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Newleaf Symbiotics Comparisons
Competitors of NewLeaf Symbiotics
NewLeaf Symbiotics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pivot Bio, Ginkgo Bioworks, Kula Bio, BioConsortia and Pluton Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| domain | founded_year | HQ Location |
Manufacturer of microbial crop nutrition products
|
|
| domain | founded_year | HQ Location |
Microbial biotech solutions for enhancing crop yields are developed.
|
|
| domain | founded_year | HQ Location |
Assay-based microbial research services are offered for industrial applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Newleaf Symbiotics
Frequently Asked Questions about NewLeaf Symbiotics
When was NewLeaf Symbiotics founded?
NewLeaf Symbiotics was founded in 2011.
Where is NewLeaf Symbiotics located?
NewLeaf Symbiotics is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Who is the current CEO of NewLeaf Symbiotics?
Brent Smith is the current CEO of NewLeaf Symbiotics.
Is NewLeaf Symbiotics a funded company?
NewLeaf Symbiotics is a funded company, having raised a total of $181M across 11 funding rounds to date. The company's 1st funding round was a Series D of $22M, raised on Nov 03, 2011.
What does NewLeaf Symbiotics do?
NewLeaf Symbiotics was founded in 2011 and is based in St. Louis, United States. Operations focus on the agriculture sector, where crop inputs are developed using Pink Pigmented Facultative Methylotrophs (PPFMs), a family of naturally occurring beneficial plant bacteria. These inputs are applied to seeds at specified concentrations to support plant growth, vigor, health, and yield increases. The company serves farming applications through these microbial solutions.
Who are the top competitors of NewLeaf Symbiotics?
NewLeaf Symbiotics's top competitors include Ginkgo Bioworks, Pivot Bio and Kula Bio.
What products or services does NewLeaf Symbiotics offer?
NewLeaf Symbiotics offers TS201 Corn Bioinsecticide, Terrasym 450 Corn Biostimulant, Terrasym 401 Soybean Biostimulant, TS601 Biofungicide, and 2 more products and services.
How many acquisitions has NewLeaf Symbiotics made?
NewLeaf Symbiotics has made 1 acquisition, including Intuitive Genomics.
Who are NewLeaf Symbiotics's investors?
NewLeaf Symbiotics has 13 investors. Key investors include SABIC, Bayer, Monsanto, Otter Capital, and S2G Ventures.